Showing Results for: “diabetes”

Analysis of large international DAPA-HF trial participants notes diabetes prevention benefit in patients with heart failure who took 10 mg of medication The SGLT2 inhibitor dapagliflozin, when used in patients with heart failure, provided a benefit in preventing type 2 diabetes (T2D), according to the study, “Effect of Dapagliflozin on the Incidence of Diabetes: A Prespecified Exploratory Analysis from DAPA-HF,” presented today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions. The original DAPA-HF trial was a phase 3 placebo-controlled international study of

The American Diabetes Association ® applauds last week’s ruling by Florida’s Second Circuit Court striking down Florida Governor DeSantis’ Executive Order banning local school boards from implementing mask mandates. The decision held that school districts can adopt health care policies over parental disagreements. The Judge referenced two Florida Supreme Court decisions supporting limiting individual rights when impacting the rights of others. The Judge further stated that the governor’s and state agencies’ actions in banning mask mandates don’t pass “Constitutional muster.” Attending school

Consumers should first check with their pharmacist to see if their metformin prescription is affected The U.S. Food and Drug Administration (FDA) recently announced a recall on extended-release (ER) metformin drugs from five manufacturers due to testing results showing N-Nitrosodimethylamine (NDMA) above the acceptable intake limit in certain lots. Type 2 diabetes patients who are currently taking an ER version of metformin and are unsure if their medication is affected, should first check with their pharmacist to see if their prescribed medication is one of the five being recalled: Apotex –

Since the CEO of the American Diabetes Association® (ADA), Charles “Chuck” Henderson, issued an apology—taking responsibility for missteps at the 2026 Scientific Sessions and personally apologizing to the five scientists by name—the ADA Executive team and Board of Directors have begun a comprehensive assessment of our practices, processes, and organizational approach to better understand what happened and identify meaningful opportunities for improvement. While this process is underway, ADA leadership and staff remain focused on the ADA’s mission and the community of over 155 million people

Drs. Neil Skolnik and Sara Wettergreen celebrate the start of Hispanic Heritage Month, exploring the role of nutrition and how cultural heritage can be embraced through food and community traditions. Our guests, Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association®, and Marina Chaparro, RD, CDCES, MPH, founder of Nutrichicos, a bilingual nutrition practice focusing on children and family nutrition, share their expertise and experiences.

Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the differences between FDA-approved medications and compounded and counterfeit medications, alongside special guests Dr. Susan Kuchera and Lisa Kessler. They will explore the factors that might influence the decision to use compounded treatments, the risks associated with these treatments, and one of our guests will share their personal experience with obesity treatment.

My son was diagnosed with type 1 diabetes at age 8. No one should have the feeling of having their child diagnosed with a disease that has no cure. It is truly a helpless feeling. At the same time, I knew that I could control my actions and do something to help. So, I got involved in and rode in our area's next Tour de Cure event. This brought our family and our son into a whole new world of good people. Over the years, we have become part of a family. Our Tour family gets together multiple times throughout the year, supports one another, and raises funds to fund education, research, and

A medida que la Costa del Golfo experimenta el impacto de huracán Laura, la comunidad de diabetes se une para asegurarse de que las personas que viven con diabetes, especialmente aquellas que dependen de insulina, reciban el apoyo necesario. La Diabetes Disaster Response Coalition (DDRC), está compuesta por las principales organizaciones de diabetes del país, insta a todas las personas con diabetes y a sus seres queridos a comunicarse si experimentan escasez de suministros para el manejo de diabetes y si necesitan información acerca de cómo mantenerse saludables y seguros. Las grandes

As Puerto Rico, U.S. Virgin Islands, Florida and Georgia brace for Tropical Storm Dorian, a potential category 2 hurricane, that is currently expected to make landfall early between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes—especially those who depend upon insulin—are fully supported. The Diabetes Disaster Response Coalition (DDRC), which is comprised of the nation’s leading diabetes organizations, is urging all people with diabetes and their loved ones to prepare by putting together a diabetes kit and making a plan to stay healthy

Today, the American Diabetes Association (ADA) sent a letter to the Centers for Disease Control and Prevention (CDC) urging them to take immediate steps to update their guidance on the risk people with type 1 diabetes (T1D) face with COVID-19 and acknowledge that people with both T1D and type 2 diabetes (T2D) should be prioritized equally in the rollout of the vaccine. This change is particularly important because more recent clinical evidence demonstrates that COVID-19 severity is more than tripled in individuals with T1D and time-sensitive, as states are now operationalizing vaccine rollouts